162 related articles for article (PubMed ID: 36778116)
1. Crosstalk between PML and p53 in response to TGF-β1: A new mechanism of cardiac fibroblast activation.
Huang D; Zhao D; Li M; Chang SY; Xue YD; Xu N; Li SJ; Tang NN; Gong LL; Liu YN; Yu H; Li QS; Li PY; Liu JL; Chen HX; Liu MB; Zhang WY; Zhao XM; Lang XZ; Li ZD; Liu Y; Ma ZY; Li JM; Wang N; Tian H; Cai BZ
Int J Biol Sci; 2023; 19(3):994-1006. PubMed ID: 36778116
[TBL] [Abstract][Full Text] [Related]
2. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
Liu Y; Zhao D; Qiu F; Zhang LL; Liu SK; Li YY; Liu MT; Wu D; Wang JX; Ding XQ; Liu YX; Dong CJ; Shao XQ; Yang BF; Chu WF
Mol Ther; 2017 Mar; 25(3):666-678. PubMed ID: 28143738
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1-PML SUMOylation-peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis.
Wu D; Huang D; Li LL; Ni P; Li XX; Wang B; Han YN; Shao XQ; Zhao D; Chu WF; Li BY
J Cell Physiol; 2019 May; 234(5):6263-6273. PubMed ID: 30246389
[TBL] [Abstract][Full Text] [Related]
4. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation.
Liu Y; Li D; Nie D; Liu SK; Qiu F; Liu MT; Li YY; Wang JX; Liu YX; Dong CJ; Wu D; Tian W; Yang J; Mu W; Li JT; Zhao D; Wang XF; Chu WF; Yang BF
Oncotarget; 2017 Jul; 8(28):45447-45458. PubMed ID: 28525371
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of SUMO-1 with ginkgolic acid alleviates cardiac fibrosis induced by myocardial infarction in mice.
Qiu F; Dong C; Liu Y; Shao X; Huang D; Han Y; Wang B; Liu Y; Huo R; Paulo P; Zhang ZR; Zhao D; Chu WF
Toxicol Appl Pharmacol; 2018 Apr; 345():1-9. PubMed ID: 29524504
[TBL] [Abstract][Full Text] [Related]
8. Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs.
Dai J; Hu Y; Niu Q; Song G; Wang H; Li S
Life Sci; 2020 Jun; 251():117607. PubMed ID: 32240679
[TBL] [Abstract][Full Text] [Related]
9. Redox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity.
Overstreet JM; Samarakoon R; Meldrum KK; Higgins PJ
Cell Signal; 2014 Jul; 26(7):1427-36. PubMed ID: 24613410
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
11. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
[TBL] [Abstract][Full Text] [Related]
12. CACUL1/CAC1 attenuates p53 activity through PML post-translational modification.
Fukuda T; Kigoshi-Tansho Y; Naganuma T; Kazaana A; Okajima T; Tsuruta F; Chiba T
Biochem Biophys Res Commun; 2017 Jan; 482(4):863-869. PubMed ID: 27889610
[TBL] [Abstract][Full Text] [Related]
13. TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.
El-Asmi F; El-Mchichi B; Maroui MA; Dianoux L; Chelbi-Alix MK
Cytokine; 2019 Aug; 120():264-272. PubMed ID: 31153006
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA lncPostn links TGF-β and p53 signaling pathways to transcriptional regulation of cardiac fibrosis.
Tao L; Qin Z; Lin L; Guo H; Liang Z; Wang T; Xu J; Xu M; Hua F; Su X
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C457-C472. PubMed ID: 38145299
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis via MDM2.
He FF; You RY; Ye C; Lei CT; Tang H; Su H; Zhang C
Cell Physiol Biochem; 2018; 46(2):451-460. PubMed ID: 29614506
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies.
Pennella MA; Liu Y; Woo JL; Kim CA; Berk AJ
J Virol; 2010 Dec; 84(23):12210-25. PubMed ID: 20861261
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1.
Kuga K; Kusakari Y; Uesugi K; Semba K; Urashima T; Akaike T; Minamisawa S
PLoS One; 2020; 15(4):e0231905. PubMed ID: 32315372
[TBL] [Abstract][Full Text] [Related]
20. Pellino1-mediated TGF-β1 synthesis contributes to mechanical stress induced cardiac fibroblast activation.
Song J; Zhu Y; Li J; Liu J; Gao Y; Ha T; Que L; Liu L; Zhu G; Chen Q; Xu Y; Li C; Li Y
J Mol Cell Cardiol; 2015 Feb; 79():145-56. PubMed ID: 25446187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
